Lithium for TBR1-related neurodevelopmental disorder
Part of Brain & nervous system, Genetic & congenital clinical trials.
This trial tests whether taking lithium for 2 years can improve symptoms in people with a TBR1 gene change that causes neurodevelopmental challenges. It aims to see if lithium is safe and helpful for this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed change in the TBR1 gene.
- Age 6 years or older.
- A parent or guardian must be able to give consent and attend all visits.
- If female and able to have children, you must use highly effective birth control during the study and for 3 months after.
- If male and able to have children, you must use condoms or avoid sex during the study and for 5 days after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if lithium can help prevent mood episodes from returning in people with bipolar disorder or major depressive disorder. It aims to see if lithium is a safe and effective longer-term treatment.
This trial looks at how lithium affects the brain in healthy people, to better understand bipolar disorder. You will not receive lithium as a treatment but as a research tool, and you'll have brain scans.
This study tests a new way to deliver lithium, a common treatment for bipolar disorder, using tiny gold particles. It aims to see if this method is safe and effective in laboratory models, which may lead to better treatments with fewer side effects.
This trial tests whether lithium can help people with Cornelia de Lange syndrome (CdLS) who have a confirmed NIPBL gene mutation. It might improve their daily life and overall well-being.
This study looks at how to predict which people with hard-to-treat depression will benefit from adding lithium to their antidepressant. If you have treatment-resistant depression and are considering lithium, this trial may help find the best treatment for you.
This study looks at how lithium works in everyday life for people with bipolar disorder. It aims to learn about real-world treatment patterns and outcomes.
Hear when a new Proven Pathogenic or Probably Pathogenic TBR1 Variant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.